Sorensen R, Etzioni A, Aziz A, Zeiger JB

Language: Spanish
References: 16
Page: 166-170
PDF size: 162.55 Kb.

ABSTRACT

World Primary Immunodeficiency Week (WPIW) 2013, is celebrated annually on 22-29 April. This year WPIW focuses on the need to test, diagnose and treat this primary immunodeficiency to promote its early detection and appropriate care. This year’s reflexions focuses on various regions of the world. The authors have taken stock of the situation in their respective areas of the world: Europe, Latin America, North Africa and Middle East, as well as Australia. Through a cross country analysis, it reflects on progress made to date to improve the life of patients with primary immunodeficiency diseases (PIDs) and the challenges that remain to address. In addition the authors address the need for continued international collaboration amongst all relevant actors to drive better access to early diagnosis and appropriate treatment and ultimately improve the life of patients with PIDs.

REFERENCES

1. Eades-Perner AM, Gathman B, Kner V, Guzman D, Veit D, Kindle G, et al. ESID Registry Working Party. The European internet-based patient and research database for primary immunodeficiencies: results 2004-06. Clin Exp Immunol. 2007;147:306–12.

2. Gathmann B, Grimbacher B, Beauté J, Dudoit Y, Mahlaoui N, Fischer A, et al. ESID Registry Working Party. The European internet-based patient and research database for primary immunodeficiencies: results 2006-2008. Clin Exp Immunol. 2009;157(Suppl 1):3–11.

3. Gathmann B, Binder N, Ehl S, Kindle G. ESID Registry Working Party. The European internet-based patient and research database for primary immunodeficiencies: update 2011. Clin Exp Immunol. 2012;167:479–91.

4. de Vries E. European Society for Immunodeficiencies (ESID) members. Patient-centred screening for primary immunodeficiency, a multi-stage diagnostic protocol designed for non-immunologists: 2011 update. Clin Exp Immunol. 2012;167:108–19.

5. Maródi LJ, Project Study Group. The creation and progress of the J Project in Eastern and Central Europe. Ann N Y Acad Sci. 2011;1238:65-73.

6. Zelazko M, Carneiro-Sampaio M, Cornejo de Luigi M, Garcia de Olarte D, Porras Madrigal O, Berrón Perez R, et al. Primary immunodeficiency diseases in the Latin America: first report from eight countries participating in LAGID. J Clin Immunol. 1998;18:161–6.

7. Leiva LE, Zelazco M, Oleastro M, Carneiro-Sampaio M, Condino-Neto A, Costa-Carvalho BT, et al. Primary immunodeficiency diseases in Latin America: the second report of the LAGID registry. J Clin Immunol. 2007;27:101–8.

8. Errante PR, Franco JL, Espinosa-Rosales FJ, Sorensen R, Condino-Neto A. Advances in primary immunodeficiency diseases in Latin America: epidemiology, research, and perspectives. Ann N Y Acad Sci. 2012;1250:62–72.

9. Condino-Neto A, Franco JL, Espinosa-Rosales FJ, Leiva LE, King A, Porras O, et al. Advancing the management of primary immunodeficiency diseases in Latin America: Latin American Society for Immunodeficiencies (LASID) Initiatives. Allergol Immunopathol (Madr). 2012;40:187–93.

10. Barbouche MR, Galal N, Ben Mustapha I, Jeddane L, Mellouli F, Ailal F, et al. Primary immunodeficiencies in highly consanguineous North African populations. Ann NY Acad Sci. 2011;1238:42–52.

11. Al-Muhsen S, Alsum Z. Primary immunodeficiency diseases in the Middle East. Ann N Y Acad Sci. 2012;1250:56–61.

12. Hassan A, Booth C, Brightwell A, Allwood Z, Veys P, Rao K, et al. Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency. Blood. 2012;120:3615–24.

13. Bousfiha AA, Jeddane L, Ailal F, Benhsaien I, Mahlaoui N, Casanova JL, et al. Primary immunodeficiency diseases worldwide: more common than generally thought. J Clin Immunol. 2013;33:1–7.

14. Mitchell R, Nivison-Smith I, Anazodo A, Tiedemann K, Shaw P, Teague L, et al. Outcomes of hematopoietic stem cell transplantation in primary immunodeficiency: a report from the Australian and New Zealand Children’s Haematology Oncology Group and the Australasian Bone Marrow Transplant Recipient Registry. Biol Blood Marrow Transplant. 2013;19:338–43.

15. Kirkpatrick P, Riminton S. Primary immunodeficiency diseases in Australia and New Zealand. J Clin Immunol. 2007;27:517–24.

16. National Blood Authority National Report on the Issue and Use of Intravenous Immunoglobulin (IVIg) for 2010–2011. Canberra; National Blood Authority. [www.nba.gov.au/ivig/ ivig-report-10-11_amended_dec2012.pdf; último acceso el 5 de marzo de 2013]